IGF1 and Hyperglycemia: MiR-16 has been found to impact insulin resistance and inhibit cell apoptosis induced by hyperglycemia, by targeting genes involved in biological processes such as insulin signaling, insulin receptor substrate (IRS) proteins 1 and 2, and insulin-like growth factor-I (IGF-I) [50].